Filling the need for trusted information on national health issues…

Trending on kff Medicare & Medicaid at 50 Individual Market Medicaid Expansion

Kaiser Daily Global Health Policy ReportIntellectual Property and Trade Search Results « » The Henry J. Kaiser Family Foundation

Intellectual Property and Trade

  • your selections
Clear Search

Filter Results

date

Tags

  • results
Health Advocates Working To Lower Cost Of HCV Medicines In LMICs, Reuters Reports

“A new battle is looming over access to antiviral medicines in developing countries — this time for treating hepatitis C [HCV] — more than a decade after a global showdown over the price of AIDS drugs in Africa,” Reuters reports. “Modern pills being launched in western markets could cure the…

Multilateral Banks Could Support LMICs’ Anti-Tobacco Policies

Noting a recent report in the New York Times about “Big Tobacco’s use of international trade and investment agreements to undermine anti-tobacco policies in low- and middle-income countries [LMICs],” Amanda Glassman, senior fellow and director of global health policy at the Center for Global Development (CGD), and Bill Savedoff, a…

Shift Donor Funding, Encourage Trade To Improve African Food Security

SciDev.Net: African agriculture needs trade not aid David Bennett, a senior member of St. Edmund’s College, Cambridge, U.K. and co-leader of the Biosciences for Farming in Africa program “…[F]or any solution to food security to be truly sustainable, people have to move from depending on aid to depending on trade.…

South Africa, Drug Companies Spar Over Intellectual Property Laws

Reuters: South Africa slams Big Pharma in generic drugs row “South Africa on Friday slammed global drug firms over a covert campaign against its planned overhaul of intellectual property laws to favor cheaper generic drugs, accusing pharmaceutical companies of a ‘satanic’ plot to commit ‘genocide.’ … South Africa is in…

‘Science Speaks’ Blog Examines Proposal Against South Africa’s Draft IP Policy

The Center for Global Health Policy’s blog “Science Speaks” reports on a proposal prepared by U.S.-based PhRMA (Pharmaceutical Research and Manufacturers of America) and the South Africa-based IPASA (Innovative Pharmaceutical Association South Africa) in response to the South African government’s Draft National Policy on Intellectual Property (IP). The “proposal says…

Top South Africa Aims To Close Drug Patent Loophole That Allows For ‘Ever-Greening’

“South Africa plans to overhaul its intellectual property laws to improve access to cheaper medicines by making it harder for pharmaceutical firms to register and roll-over patents for drugs, a senior official said on Monday,” Reuters reports. The efforts to close “a loophole known as ‘ever-greening,’ whereby drug companies slightly…

HHS Global Health Official Discusses Tobacco-, Drug Patent-Related Trade Negotiations

Inside U.S. Trade features an interview with HHS Assistant Secretary for Global Affairs Nils Daulaire, who discusses how “the department is playing a larger role than ever before in the development of U.S. trade policy, including on sensitive issues in the Trans-Pacific Partnership (TPP) negotiations like a draft proposal for…

U.S. Proposes Talks Aimed At Improving Food Security At Upcoming WTO Meeting

“The United States said on Tuesday it was prepared to examine how agricultural policy reform could boost global food security as part of a package of commitments at the World Trade Organization’s [WTO] upcoming meeting in December,” Reuters reports. “‘The United States agrees with India and other proponents that enhancing…

Media Outlets Examine Reaction To India’s Supreme Court Ruling On Novartis Patent Case

“In a decisive victory for India’s pharmaceutical industry, India’s Supreme Court rejected Novartis’ patent application for the cancer drug Glivec on Monday, ending a seven-year battle by the Swiss drug maker to get a patent in India on its powerful leukemia drug,” Time reports (Mahr, 4/1). “The decision means generic…